The term “DIDMOAD” syndrome – an acronym for the characteristic symptoms – serves as an alternative name for this autosomal recessive neurodegenerative disease, which was first described in 1938: Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness/Deafness. In the majority of patients, mutations in the WFS1 gene can be detected.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Atrial fibrillation
Anticoagulation after catheter ablation – for how long?
- Wound treatment and dermal defect coverage
Fish skin matrix for the treatment of complex ulcers
- Well-being of the medical profession in primary care
Findings of a nationwide survey in Switzerland
- Severe asthma and CRSwNP
Multidisciplinary collaboration between pneumology, allergology and ENT
- Myelofibrosis
New findings on the role of inflammation in pathogenesis
- Incretin mimetics for obesity and prediabetes
Liraglutide, semaglutide and tirzepatide: considerable evidence base
- Treatment of infected wounds and wounds at risk of infection
Focus on an interdisciplinary perspective
- Chronic and hard-to-heal wounds